James Brian Windsor insider trades
Open-market stock purchases and sales by James Brian Windsor, See Remarks at Rein Therapeutics, Inc, from SEC Form 4 filings since Oct 25, 2019.
Track record: 17% of 6 scored buys are up 5% or more since purchase, averaging -30%.
Get free alerts when James Brian Windsor files a new trade →